What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
about
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidencesNeuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophreniaThe neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.Rapid metabolic evolution in human prefrontal cortexDietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.Neuroimaging studies in schizophrenia: an overview of research from Asia.Glutamate-mediated excitotoxicity in schizophrenia: a review.Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis.Traditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of bangladesh to treat schizophrenia like psychosis.Multivoxel proton MR spectroscopy used to distinguish anterior cingulate metabolic abnormalities in patients with schizophrenia.Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1)Medial-frontal cortex hypometabolism in chronic phencyclidine exposed rats assessed by high resolution magic angle spin 11.7 T proton magnetic resonance spectroscopyMagnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands.Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia.Executive function, neural circuitry, and genetic mechanisms in schizophrenia.Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis.Mitochondrial dysfunction in schizophrenia: an evolutionary perspective.Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy.Proton MRS in twin pairs discordant for schizophrenia.Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels.Neuregulin-1 signaling in schizophrenia
P2860
Q24644046-7568FCEA-9FC5-4428-A4E2-46670D198C53Q27026382-23333B63-C961-4795-9FA3-8D22F27930A6Q28568657-64FED301-D0FA-4C6B-A81B-441C1A8F213BQ28741042-F4226614-A948-44AF-9AC1-2C3AAEADB188Q30372082-CC2C96E3-2B45-49EF-BEDC-991DE7B20D2EQ30484119-BC309B6D-59E4-4BFE-A93D-2E2341D127BFQ30573043-0818F5D6-1055-4887-9F2F-CEACC80C8D46Q30845062-2D7C66B2-3E07-4E2C-A188-890D06469392Q31048306-DFA17FDF-6E17-4A04-9E55-4A02422C797FQ33271816-13104A48-91DE-40BC-B6D6-4BB434435741Q33429548-D7CCA8EE-9D38-4C2D-8733-82415F13B5A3Q33885557-DA05CB98-9516-4C3D-A7FC-C95F5DFE4CC1Q33908361-CB2F9315-C7A4-4685-8347-91C1B53CE8D0Q34013484-1400AE3E-2747-4F93-B99F-FDFA17A66B2CQ34066948-36A3D46A-F6A4-4686-BCE0-1D584AC5162AQ34250017-3B2F030F-1FFA-4A4B-A08E-3EA5610DF3FBQ35158156-64F0B107-2821-422F-9E83-D505CF35F1C6Q35953115-6A88CDFB-3081-43A0-9AED-B7D9BBE3CD45Q36069511-CF722246-55E9-4CC2-A937-A4F6B300464AQ36359827-8FFD979A-F105-4E33-B3B5-C2147841A1ECQ36579976-D729B633-44B1-416D-AF90-E2E45FCE53F3Q37480047-15A1B55F-DC94-45E6-8529-867203A55F7EQ37810163-7F3D6096-F8B1-483E-8309-843908375335Q38259827-CE32298C-3D64-4895-BCEB-3D537FD33EF5Q44126853-1ABC7B67-327C-48FB-B58B-1ABCBBA6577AQ46470298-FD348E8F-570E-4199-878E-5BA9DFACAE85Q49342366-B4CB0F58-FD96-4CD1-B0B9-5D9FC3447BEAQ58621554-34AF1F62-9FA3-4F81-B6B2-9DF399F41C12
P2860
What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
What have we learned from prot ...... izophrenia? A critical update.
@ast
What have we learned from prot ...... izophrenia? A critical update.
@en
type
label
What have we learned from prot ...... izophrenia? A critical update.
@ast
What have we learned from prot ...... izophrenia? A critical update.
@en
prefLabel
What have we learned from prot ...... izophrenia? A critical update.
@ast
What have we learned from prot ...... izophrenia? A critical update.
@en
P1476
What have we learned from prot ...... hizophrenia? A critical update
@en
P2093
Juan Bustillo
P304
P356
10.1097/01.YCO.0000214337.29378.CD
P577
2006-03-01T00:00:00Z